Peer Review History

Original SubmissionJanuary 26, 2022
Decision Letter - Dragan Hrncic, Editor

PONE-D-22-02598

Reference gene selection within the rat brain under mild intermittent ketosis induced by supplementation with medium-chain triglycerides

PLOS ONE

Dear Dr. Schwarz,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:- please do follow directions of reviewers to improve your manuscript 

==============================

Please submit your revised manuscript by Aug 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Prof. Dragan Hrncic, MD, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Thank you for stating the following in your Competing Interests section: 

“The authors declare no conflict of interest.”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

This information should be included in your cover letter; we will change the online submission form on your behalf.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In the present manuscript PONE-D-22-02598 authors investigated the effects of expression stability of 9 housekeeping genes widely used as reference and selected suitable reference genes for RT-qPCR analysis within the brain structures in rat model of mild ketosis. They used contemporary methodology and generated a large number of interesting results with potential interest to genetics-oriented readers. The manuscript should be improved for clarity according to provided comments and directions.

Minor points

Title

- Title should be changed to better reflect a full content of the manuscript.

- Maybe, one form of the title could be:” Reference gene expression stability within the rat brain under mild intermittent ketosis induced by supplementation with medium-chain triglycerides”

General

- English should be checked with corrections of some typos.

Abstract

- Please, introduce all abbreviations in appropriate places.

- Avoid starting this section with an abbreviation on the first place of the sentence.

- Address the impact of model of mild ketosis induced by medium-chain triglyceride supplementation and its relationship to genes expression.

Introduction

- Add a paragraph and explain the importance of selected genes, and describe some other studies which investigated the similar problematic.

- At the end of this section should be placed the aim of this study.

Material and methods

- In Animals and study design subsection, please add the number of ethical permission.

- Also, your manuscript will benefit by adding of one new figure with experimental timeline, which should be placed in Animals and study design subsection.

Results

- In Figures 3-5, for more clarity, colors could be additionally added, but it is not mandatory

Discussion

- Some typos should be corrected.

Reviewer #2: Positive comments

1. The paper is well written

2. The rationale behind executing the project is sound

3. The selection of initial reference genes for testing was based on the role of different genes in cell functions and also based on available literature

Revision Needed

1. Authors need to explain the PCR efficiency of the primers in the manuscript

2. Why were the authors using 2 mL/kg daily? Please give some supportive references.

3. *Line no. : 154: "RefFinder® online tool (https://www.heartcure.com.au/reffinder/)". Delete the website address as it was mentioned once in line 129.

4. In general, the authors should be writing medium-chain triglycerides (MCT) as either ‘MCT’ or ‘MCT oil’ in whole article.

5. Though gene expression was normalized with the three reference genes selected, this data still needs to be validated for gene expression with the bottom genes. This further proves the validity of the reference genes selected (Sahu., et al 2018)

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Nikola Šutulović

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Prof. Dragan Hrncic, MD, PhD

Academic Editor

PLOS ONE

Dear Dr. Hrncic,

Thank you and the reviewers for working on our manuscript and all the valuable comments and suggestions. We have prepared a revised version of the article with the changes marked. Briefly, we have corrected some typos throughout the manuscript and changed the title according to the reviewer's suggestion.

Please find the detailed answers to the reviewers’ comments below.

Reviewer 1

«Title

- Title should be changed to better reflect a full content of the manuscript.

- Maybe, one form of the title could be:” Reference gene expression stability within the rat brain under mild intermittent ketosis induced by supplementation with medium-chain triglycerides”».

We changed the Manuscript title according to the reviewer’s suggestion.

«Abstract

- Please, introduce all abbreviations in appropriate places.

- Avoid starting this section with an abbreviation on the first place of the sentence.

- Address the impact of model of mild ketosis induced by medium-chain triglyceride supplementation and its relationship to genes expression.»

We edited the abstract to mention the full name of the method and added abbreviations’ disambiguation whereby needed (e.g. MCT, RT-qPCR). We also added two sentences describing our model of mild ketosis: this approach allows to reproduce certain neuroprotective effects of the classical ketogenic diet while avoiding its adverse effects. Ketogenic treatment targets multiple metabolic pathways, which may affect the reference gene expression.

«Introduction

- Add a paragraph and explain the importance of selected genes, and describe some other studies which investigated the similar problematic.

- At the end of this section should be placed the aim of this study.»

We rearranged this section, moving the paragraph about the aim of the study to the end of the section. We also added information about the functional properties of the analyzed gene products.

«Material and methods

- In Animals and study design subsection, please add the number of ethical permission.

- Also, your manuscript will benefit by adding of one new figure with experimental timeline, which should be placed in Animals and study design subsection.»

We added the permission number and created a figure with the experimental timeline (Figure 1 in the revised version).

«Results

- In Figures 3-5, for more clarity, colors could be additionally added, but it is not mandatory»

We made colored versions of the graphs (figures 4-6 in the revised manuscript).

Reviewer 2.

1. «Authors need to explain the PCR efficiency of the primers in the manuscript».

We added the information about the range of measured PCR efficiencies to the Method section. The full information is presented in the Supplementary figures S4-S6.

2. «Why were the authors using 2 mL/kg daily? Please give some supportive references.».

We used this dosage to mimic typical low doses used in human studies. We added the supporting references in the Materials and Methods section.

3. «*Line no. : 154: "RefFinder® online tool (https://www.heartcure.com.au/reffinder/)". Delete the website address as it was mentioned once in line 129.»

We deleted the repeated mention of the URL.

4. In general, the authors should be writing medium-chain triglycerides (MCT) as either ‘MCT’ or ‘MCT oil’ in whole article.

We chose MCT for the whole article in the revised version.

5. Though gene expression was normalized with the three reference genes selected, this data still needs to be validated for gene expression with the bottom genes. This further proves the validity of the reference genes selected (Sahu., et al 2018)

We would like to thank Reviewer 2 for this suggestion, but we decided not to change our article in this way. Of course, the calculations for the genes of interest to the unstable genes could be used as a vivid illustration of the biases resulting from incorrect normalization. However, it would be a good approach if we were working with «marker» genes that moderately changed under the analyzed experimental conditions. In our case, we work with a new model, which is not well described in rats. So, we feel that the calculation of custom gene of interest expression normalized to different references would make our article more complicated and would not clarify the results.

We are looking forward for your review of the revised manuscript.

Alexander Schwarz

Ph.D., Research Fellow

Laboratory of Molecular Mechanisms of Neuronal Interactions

I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry

St. Petersburg, Russia

Aleksandr.Pavlovich.Schwarz@gmail.com

Attachments
Attachment
Submitted filename: Schwarz_et_al_Response_to_Reviewers.docx
Decision Letter - Dragan Hrncic, Editor

Reference gene expression stability within the rat brain under mild intermittent ketosis induced by supplementation with medium-chain triglycerides

PONE-D-22-02598R1

Dear Dr. Schwarz,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Prof. Dragan Hrncic, MD, PhD 

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Dragan Hrncic, Editor

PONE-D-22-02598R1

Reference gene expression stability within the rat brain under mild intermittent ketosis induced by supplementation with medium-chain triglycerides

Dear Dr. Schwarz:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Dragan Hrncic

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .